De-risking and accelerating clinical trials through more sensitive and complete data about patients’ function in real-life
Innovation in pharma is risky and slow because of the bottleneck of clinical trials, which do not produce adequate data:
70-75% of all pharma R&D spend
Up to 1 in 3 fail to produce required data
Typically take 7-10 years
Cost >$10s of Millions
Clinical trials are risky, slow and costly because of inadequate data:
Slow & difficult to recruit & retain participants and ensure adherence
Often subjective or not quantitative
Not sensitive enough
Not complete, lack relevant context
Not real-world, does not represent meaningful changes in function in real-life
WKD.SMRT’s solution is a user-friendly in-home IoT+AI platform that delivers superior data for neurodegenerative and other diseases that involve motor dysfunction or changes in activity in real-life
WKD.SMRT’s platform combines multiple IoT sensor nodes with edge computing for AI processing, a tablet for patient interaction, and a hub that provides WiFi and 5G for connectivity to WKD.SMRT’s cloud, which delivers data-as-a-service via secure APIs
Insights
About Us
We are the right team, at the right time. WKD.SMRT was founded by a team of professors and CTOs from MIT and Dartmouth. We recognize the potential of smart-home technologies to accelerate clinical trials. With technology and medical expertise, and entrepreneurial experience we are in the right place to innovate. Recent enabling innovation, in particular in vision, sensing and machine learning, now makes this doable.
Let’s Talk
Are you responsible for implementing digital technology to clinical trials in your organization?
Do you have a burning passion to transform how clinical trials are run?
Or just wicked smart and curious about what we are making?
Newsletter Sign Up
Stay involved with our latest developments.
Join Our Team
Interested in joining our team of skilled innovative individuals?